STALICLA Initiates US DDI Study Of STP7 For Cocaine Use Disorder
02 May 2024 //
GLOBENEWSWIRE
STALICLA signs CRADA with US NIDA to cover PIII development of mavoglurant
08 Mar 2023 //
GLOBENEWSWIRE
02 May 2024 //
GLOBENEWSWIRE
08 Mar 2023 //
GLOBENEWSWIRE